| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
9e-06 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
7e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0001 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
| mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0004 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0004 |
| mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |